Rogco LP’s BioMarin Pharmaceuticals BMRN Stock Holding History

Rogco LP’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-38	Closed	-$2.67K	–	223
2024 Q3	$2.67K	Hold	38	–	–	﹤0.01%	225
2024 Q2	$3.13K	Hold	38	–	–	﹤0.01%	226
2024 Q1	$3.32K	Hold	38	–	–	﹤0.01%	226
2023 Q4	$3.66K	Hold	38	–	–	﹤0.01%	225
2023 Q3	$3.36K	Buy	+38	New	+$3.38K	﹤0.01%	234

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Rogco LP's BMRN Position: Q4 2024 in Review

Rogco LP sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2024, closing a stake of 38 shares — an estimated $2.67K sold.

Rogco LP first reported a position in BMRN in Q3 2023 and held it in 5 quarters. The position peaked at $3.66K in Q4 2023. 543 funds tracked by Wall St. Rank hold BMRN as of Q4 2024.

Rogco LP reported no remaining BioMarin Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Rogco LP sold 38 BioMarin Pharmaceuticals shares in Q4 2024, an estimated $2.67K.
Rogco LP first reported a position in BioMarin Pharmaceuticals in Q3 2023 and held it in 5 quarters.
Rogco LP's BioMarin Pharmaceuticals position peaked at $3.66K in Q4 2023.
543 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2024.

Based on Rogco LP's 13F filing for Q4 2024, filed 31 Jan 2025.